Incidence and mortality of bullous pemphigoid in France

Journal of Investigative Dermatology

Volumn 132, Issue 8, 2012, Pages 1998-2004

  Joly, Pascal ^a   Baricault, Sophie ^a   Sparsa, Agnès ^b   Bernard, Philippe ^c   Bédane, Christophe ^b   Duvert Lehembre, Sophie ^a   Courville, Philippe ^d   Bravard, Pierre ^e   Rémond, Brigitte ^f   Doffoel Hantz, Valérie ^b   Bénichou, Jacques ^d  

^a UNIVERSITÉ DE ROUEN   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e LE HAVRE HOSPITAL   (France)

^f Evreux General Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; BULLOUS PEMPHIGOID; CLINICAL FEATURE; EVALUATION; FATALITY; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE;

EID: 84863934652     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.35     Document Type: Article

References (38)

1. Bastuji-Garin S, Joly P, Lemordant P et al. (2011) Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol 131:637-43
2. Bastuji-Garin S, Joly P, Picard-Dahan C et al. (1996) Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol 132:272-6
3. Bernard P, Vaillant L, Labeille B et al. (1995) Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 131:48-52
4. Colbert RL, Allen DM, Eastwood D et al. (2004) Mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol 122:1091-5
5. Cordel N, Chosidow O, Hellot MF et al. (2007) Neurological disorders in patients with bullous pemphigoid. Dermatology 215:187-91
6. Cordel N, Courville P, Martel P et al. (2002) Extensive erosive bullous pemphigoid: an atypical and serious clinical variant. Br J Dermatol 146:537-9
7. Cortés B, Marazza G, Naldi L et al. (2011) Mortality of bullous pemphigoid in Switzerland: a prospective study. Br J Dermatol 165:368-74
8. Courville P, Kupfer I, Gilbert D et al. (2000) Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies. Ann Pathol 20:564-9
9. Cozzani E, Parodi A, Rebora A et al. (2001) Bullous pemphigoid in Liguria: a 2-year survey. J Eur Acad Dermatol Venereol 15:317-9
10. de Pedro-Cuesta J, Virués-Ortega J, Vega S et al. (2009) Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008. BMC Neurol 19:55
11. Fernandez-Viadero C, Arce Mateos F, Verduga Velez R et al. (2004) Blisters in a nursing home: bullous pemphigoid more often than we think? J Am Geriatr Soc 52:1405-6
12. Grattan CE (1985) Evidence of an association between bullous pemphigoid and psoriasis. Br J Dermatol 113:281-3
13. Gudi VS, White MI, Cruickshank N et al. (2005) Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-East Scotland. Br J Dermatol 153:424-7
14. Joly P (2008) Incidence of bullous pemphigoid and pemphigus vulgaris. BMJ 337:a209
15. Joly P, Benichou J, Lok C et al. (2005a) Prediction of survival for patients with bullous pemphigoid: a prospective study. Arch Dermatol 141:691-8
16. Joly P, Benichou J, Saiag P et al. (2005b) Response to: mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol 124:664-5
17. Joly P, Courville P, Lok C et al. (2004) Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera. Dermatology 208:16-20
18. Joly P, Gilbert D, Thomine E et al. (1997) Relationship between the in vivo localization and the immunoblotting pattern of anti-basement membrane zone antibodies in patients with bullous pemphigoid. Arch Dermatol 133:719-24
19. Joly P, Roujeau JC, Benichou J et al. (2002) A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 31:321-7
20. Joly P, Roujeau JC, Benichou J et al. (2009) A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol 129:1681-7
21. Jung M, Kippes W, Messer G et al. (1999) Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 41:266-8
22. Khellaf M, Quantin C, d'Athis P et al. (2010) Age-period-cohort analysis of stroke incidence in Dijon from 1985 to 2005. Stroke 41:2762-7
23. Lamb PM, Abell E, Tharp M et al. (2006) Prodromal bullous pemphigoid. Int J Dermatol 45:209-14
24. Langan SM, Groves RW, West J (2011) The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. J Invest Dermatol 131:631-6
25. Langan SM, Smeeth L, Hubbard R et al. (2008) Bullous pemphigoid and pemphigus vulgaris: incidence and mortality in the UK: population based cohort study. BMJ 337:a180
26. Levine N, Freilich A, Barland P (1979) Localized pemphigoid simulating dyshidrosiform dermatitis. Arch Dermatol 115:320-1
27. Marazza G, Pham HC, Schärer L et al. (2009) Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol 161:861-8
28. Mura T, Dartigues JF, Berr C (2010) How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050. Eur J Neurol 17:252-9
29. Ormerod AD, Daly BM, Main RA et al. (1984) Bullous pemphigoid resembling erythema annulare centrifugum. Br J Dermatol 110:378-9
30. Parker S, Dyson S, Brisman S et al. (2008) Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States. J Am Acad Dermatol 59:582-8
31. Ramaroson H, Helmer C, Barberger-Gateau P et al. (2003) Prevalence of dementia and Alzheimer's disease among subjects aged 75 years or over: updated results of the PAQUID cohort. Rev Neurol (Paris) 159:405-11
32. Rzany B, Partscht K, Jung M et al. (2002) Risk factors for lethal outcome in patients with bullous pemphigoid: low serun albumin level, high dosage of glucocorticosteroids, and old age. Arch Dermatol 138:903-8
33. Schmidt E, Sitaru C, Schubert B et al. (2002) Subacute prurigo variant of bullous pemphigoid: autoantibodies show the same specificity compared with classic bullous pemphigoid. J Am Acad Dermatol 47:133-6
34. Strohal R, Rappersberger K, Penamberger H et al. (1993) Nonbullous pemphigoid: prodrome of bullous pemphigoid or a distinct pemphigoid variant? J Am Acad Dermatol 29:293-9
35. Taghipour K, Chi CC, Vincent A et al. (2010) The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study. Arch Dermatol 146:1251-4
36. Ukraintseva S, Sloan F, Arbeev K et al. (2006) Increasing rates of dementia at time of declining mortality from stroke. Stroke 37:1155-9
37. Vaillant L, Bernard P, Joly P et al. (1998) Evaluation of clinical criteria for diagnosis of bullous pemphigoid. Arch Dermatol 134:1075-80
38. Zillikens D, Wever S, Roth A et al. (1995) Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 131:957-8